MMPs: Architects of Tumor Microenvironment
Matrix metalloproteinases (MMPs), a family of zinc-dependent endopeptidases, are capable of degrading almost all protein components of the extracellular matrix (ECM). MMPs have garnered attention as potential therapeutic targets for conditions like cancer, cardiovascular diseases, and inflammatory disorders. Researchers are exploring the application of MMPs in addressing health issues, including their benefits for diagnosis, prognosis, or treatment of various diseases.
Sino Biological is actively contributing to MMP research by providing a comprehensive range of recombinant MMP proteins and associated antibodies, including MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-10, MMP-12, MMP-19, and MMP-26. These products are invaluable in understanding MMPs' intricate roles in human health, advancing drug development, and improving disease treatment strategies.